Donanemab and lecanemab are targeted antibody drugs that slow down the early stages of Alzheimer’s. They represent a huge ...

By binding to amyloid, the drugs are designed to help clear the buildup and slow down cognitive decline. Donanemab has been ...

Diversity in clinical trials can positively impact patient care and outcomes, particularly among minority populations, Anita ...

Risks of participating: There is a risk of side effects during Phase 1 clinical trials because researchers do not yet know which dose of treatment a person can tolerate without side effects.

Weight-loss jabs have grown massively in popularity over the past year, but a team of scientists has now found that the ...

Surya Gummadi, president of Cognizant Americas, discusses the transformative impact of AI in health care, emphasizing ...

Using a recent survey on the adoption of AI/ML conducted by the Tufts CSDD as context, pharma leaders discussed how they are using these technologies to optimize trial execution.

Viome is combining science and AI to provide dietary advice and detect diseases. Two company execs share how they use the MVP ...

On May 30, a team of researchers funded by the National Institutes of Health got the word: Funding for their vaccine ...

When you swallow a vitamin or eat a meal, the nutrients you've ingested flow into your stomach, break down, and enter your ...